Used in pharmaceutical research as a potent and selective antagonist of the serotonin 5-HT2C receptor. This compound is investigated for its potential in treating central nervous system disorders, including depression, anxiety, and obesity, due to its ability to modulate serotonin signaling pathways. Its structural features allow for high affinity binding to the receptor subtype, making it a valuable tool in neuropharmacology studies. Additionally, it serves as a lead compound in the development of novel therapeutics targeting metabolic and psychiatric conditions.